Gerard Ber
CIK 1762144 · last filed 2026-06-03
Gerard Ber is a corporate insider who has filed 24 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing shows the insider had shares withheld for taxes covering $36.8K of LNTH on Jun 3, 2026. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.83M
3
24
-$1.58M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LNTH | Director | 27,118 | $104.52 | $2.83M | -$1.57M | 15 | 2026-06-03 |
| Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Director | 1,608 | $8.61 | $13.8K | -$8.7K | 6 | 2024-06-11 |
| PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Director | — | — | — | $0 | 2 | 2019-12-17 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | LNTH | Tax (F) | −381 | -$36.8K | EDGAR |
| 2026-05-18 | LNTH | Grant (A) | +4,137 | $0 | EDGAR |
| 2025-05-16 | LNTH | Grant (A) | +2,537 | $0 | EDGAR |
| 2025-05-13 | LNTH | Tax (F) | −396 | -$32.4K | EDGAR |
| 2024-08-14 | LNTH | Sell (S) | −15,500 | -$1.50M | EDGAR |
| 2024-06-11 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Sell (S) | −722 | -$8.7K | EDGAR |
| 2024-05-15 | LNTH | Tax (F) | −629 | -$54.5K | EDGAR |
| 2024-05-13 | LNTH | Grant (A) | +2,635 | $0 | EDGAR |
| 2023-06-09 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +2,330 | $0 | EDGAR |
| 2023-05-15 | LNTH | Grant (A) | +2,012 | $0 | EDGAR |